New research predicts a "substantial rise" in uterine cancer cases and deaths in the U.S. through 2050, with Black women most ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to ...

Novel drug combinations that improve survival outcomes, questions about treatment sequence, and encouraging results in chemo-resistant disease are highlights in ovarian cancer from ASCO 2025.

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.

Hearing the Ovarian Cancer Whisper, or H.O.W., is a Jupiter-based nonprofit providing emotional and financial support to hundreds of local women battling ovarian cancer.

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival compared with neoadjuvant chemo and interval cytoreductive surgery.

5582Background: The high mortality of Ovarian cancer (OC) has been attributed to late-stage diagnosis and the lack of an effective early detection strategy, particularly for asymptomatic women. In ...

Following a third failed bankruptcy maneuver by Johnson& Johnson, trial lawyers with Dallas- based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer after ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...